Adil Javed to Alemtuzumab
This is a "connection" page, showing publications Adil Javed has written about Alemtuzumab.
Connection Strength
0.333
-
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis. J Neuroinflammation. 2020 Jun 15; 17(1):189.
Score: 0.179
-
A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab. Mult Scler. 2019 05; 25(6):811-818.
Score: 0.154